Silvant Capital Management’s Boston Scientific BSX Stock Holding History

Silvant Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171	Sell	4 -11,007	-100%	-$598K	﹤0.01%	383
2026 Q1	$691K	Buy	11,011 +1,024	+10%	+$81.9K	0.02%	162
2025 Q4	$952K	Buy	9,987 +59	+0.6%	+$5.78K	0.03%	152
2025 Q3	$969K	Buy	9,928 +1,196	+14%	+$124K	0.03%	151
2025 Q2	$938K	Sell	8,732 -34,028	-80%	-$3.44M	0.04%	148
2025 Q1	$4.31M	Hold	42,760	–	–	0.2%	65
2024 Q4	$3.82M	Hold	42,760	–	–	0.16%	80
2024 Q3	$3.58M	Sell	42,760 -34,752	-45%	-$2.74M	0.16%	86
2024 Q2	$5.97M	Hold	77,512	–	–	0.26%	54
2024 Q1	$5.31M	Hold	77,512	–	–	0.25%	62
2023 Q4	$4.48M	Hold	77,512	–	–	0.24%	65
2023 Q3	$4.09M	Hold	77,512	–	–	0.25%	63
2023 Q2	$4.19M	Hold	77,512	–	–	0.24%	72
2023 Q1	$3.88M	Hold	77,512	–	–	0.25%	73
2022 Q4	$3.59M	Sell	77,512 -803	-1%	-$34.8K	0.25%	78
2022 Q3	$3.03M	Buy	+78,315	New	+$3.14M	0.21%	84

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Silvant Capital Management's BSX Position: Q2 2026 in Review

Silvant Capital Management reduced its Boston Scientific (BSX) stake by 100% in Q2 2026, selling an estimated $598K and leaving 4 shares worth $171. The position accounts for ﹤0.01% of the portfolio, ranked #383.

Silvant Capital Management first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.97M in Q2 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Silvant Capital Management held 4 shares of Boston Scientific worth $171 as of Q2 2026.
Silvant Capital Management sold 11,007 Boston Scientific shares in Q2 2026, an estimated $598K.
Boston Scientific made up ﹤0.01% of Silvant Capital Management's portfolio in Q2 2026, its #383 holding.
Silvant Capital Management first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
Silvant Capital Management's Boston Scientific position peaked at $5.97M in Q2 2024.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Silvant Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.